Vascular Cell Adhesion Molecule-1 and Endothelial Leukocyte Adhesion Molecule-1 as Markers of Atherosclerosis of NIDDM
American Journal of Life Sciences
Volume 3, Issue 1, February 2015, Pages: 22-26
Received: Dec. 13, 2014; Accepted: Dec. 27, 2014; Published: Jan. 30, 2015
Views 2273      Downloads 138
Mohammed E. Al-Ghurabi, Department of biology, College of Science, University of Kufa, AL- najaf, Iraq
Ali A. Muhi, Department of biology, College of Science, University of Kufa, AL- najaf, Iraq
Dhefaf H. Al-Mudhafar, Department of biology, College of Science, University of Kufa, AL- najaf, Iraq
Article Tools
Follow on us
Background: Leukocyte adhesion to arterial endothelial cells is thought to be an important step in the development of atherosclerosis, Adhesion molecules such as vascular cell adhesion molecule-1 (VCAM-1) and the endothelial-leukocyte adhesion molecule-1 (ELAM-1) play an essential role in the early stages of atherogenesis of diabetic patients. Materials and Methods: The study was conducted on 80 male divided into two groups 60 of them had diabetes mellitus and 20 subjects were normal healthy individuals served as a control group. Enzyme linked immune sorbent assay (ELISA) was used for the measurement of serum VCAM-1and ELAM-1and WBC assay executed by automatic hematology analyzer the information of patients were obtained through a questionnaire consisted Patients with other diseases were excluded from the current investigation. Results: This result revealed elevated level of serum VCAM-1and ELAM-1 of Diabetes patients compared with healthy group also differentiation count reveal elevated count of WBC, Neutrophil, Lymphocyte, Monocyte, Eosinophil, Basophil in Diabetes patient as compare with HT group.
To cite this article
Mohammed E. Al-Ghurabi, Ali A. Muhi, Dhefaf H. Al-Mudhafar, Vascular Cell Adhesion Molecule-1 and Endothelial Leukocyte Adhesion Molecule-1 as Markers of Atherosclerosis of NIDDM, American Journal of Life Sciences. Vol. 3, No. 1, 2015, pp. 22-26. doi: 10.11648/j.ajls.20150301.15
Krolewski A, Warram J, Valsania P, Martin B, Laffel L, Christlieb A. Evolving natural history of coronary artery disease in diabetes mellitus. Am. J. Med 1991; 90:56S-61S.
Factor S, Segal B, van Hoeven K. Diabetes and coronary vascular disease. Coron. Art. Dis 1991;3:4-10.
Nowak M1, Wielkoszyński T, Marek B, Kos-Kudła B, Swietochowska E, Siemińska L, et al. Blood serum levels of vascular cell adhesion molecule (sVCAM-1), intercellular adhesion molecule (sICAM-1) and endothelial leucocyte adhesion molecule-1 (ELAM-1) in diabetic retinopathy. Clin Exp Med 2008; 8(3):159-64.
Cybulsky M, Gimbrone M. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis, Science. Wash. DC 1991;251:788-791.
Li H, Cybulsky M, Gimbrone M, Libby P.An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler. Thromb 1993;13:197-204..
Richardson M, Hadcock S, DeReske M, Cybulsky M. Increased expression in vivo of VCAM-1 and E-selectin by the aortic endothelium of normolipemic and hyperlipemic diabetic rabbits. Arterioscler. Thromb 1994;14:760-769.
O’Brien KD, Allen MD, McDonald TO, Chait A, Harlan JM, Fishbein D, et al. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques: implicationsfor the mode of progression of advanced coronary atherosclerosis, J ClinI n v e s t 1993;92:945–951.
Fasching P, Waldhausl W, Wagner O. Elevated circulating adhesion molecules in NIDDM; potential mediators in diabeticmacroangiopathy, Diabetologia 1996;39:1242-1244.
Albertini JP, Valensi P, Lormeau B,Aurousseau MH, Ferriere F, Attali JR,Gattegno L. Elevated concentrations ofsoluble E-selectin and vascular cell adhesion molecule-1 in NIDDM: effect of intensiveinsulin treatment.Diabetes Care 1998;21:1008–1013.
Kado S, Wakatsuki T, Yamamoto M, Nagata N. Expression of ICAM-1 induced by high glucose concentrations in human aortic endothelial cells. Life Sci 2001;68: 727-737.
Morigi M, Angioletti S, Imberti B, DonadelliR, Micheletti G, Figliuzzi M, et al.Leukocyte-endothelialinteraction is augmented by high glucoseconcentrations and hyperglycemia in aNF-kB-dependent fashion. J Clin Invest 1998;101:1905–1915.
Matsumoto K, Miyake S, Yano M, Ueki Y,Tominaga Y. High serum concentrationsof soluble E-selectin in patients with impairedglucose tolerance with hyperinsulinemia. Atherosclerosis 2000;152:415–420.
Yong Woo Lee, Paul H. Kim, Won Hee Lee, Anjali A. Interleukin-4, Oxidative Stress, Vascular Inflammation and Atherosclerosis. Biomol Ther 2010;18(2): 135–144.
Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory Injury, FASEB J 1994;8:504–512.
Springer TA. Adhesion receptors of the immune system, N a t u r e 1990;346 : 425 – 434.
O’Brien KD, McDonald TO, Chait A, Allen MD, Alpers CE. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. C i r c u l a t i o n 1996;93:672–682.
Libby P, Li H. Vascular cell adhesion molecule-1 and smooth muscle cell activation during atherogenesis, J Clin Invest 1993;92:538–539.
Alon R, Kassner PD, Carr MW, Finger EB, Hemler ME, Springer TA. The integrin VLA-4 supports tethering and rolling in flow on VCAM-1, J Cell Biol 1995;128:1243–1253.
Luscinskas FW, Kansas GS, Ding H, Pizcueta P, Schleiffenbaum BE, Tedder TF, Gimbrone MA Jr. Monocyte rolling, arrest and spreading on IL-4-activated vascular endothelium under flow is mediated via sequential action of L-selectin,beta 1-integrins, and beta 2-integrins, J Cell Biol 1994;125:1417–1427.
Jager A, van Hinsbergh VW, Kostense PJ, Emeis JJ, Nijpels G, Dekker JM, et al.Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes, the Hoorn study, Diabetes 2000;49(3):485-91.
Davies MJ, Gordon JL, Gearing AJ, Pigott R, Woolf N, Katz D, et al. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis, J Pathol 1993;171:223–229.
Gearing AJ, Hemingway I, Pigott R, Hughes J, Rees AJ, Cashman SJ. Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1:pathological significance, Ann N Y Acad Sci 1992;667:324–331.
Gearing AJ, Newman W. Circulating adhesion molecules in disease, Immunol To d a y 1993;14:506–512.
Schmidt AM, Hori O, Chen JX, Li JF, Crandall J, Zhang J, et al. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice: a potential mechanism for the accelerated vasculopathy of diabetes, J Clin Invest 1995;96:1395–1403.
Jang Y, Lincoff AM, Plow EF, Topol EJ. Cell adhesion molecules in coronary artery disease, J Am Coll C a r d i o l 1994; 24:1591–1601.
Kawamura T, Umemura T, Kanai A, Uno T, Matsumae H, Sano T, et al. The incidence and characteristics of silent cerebral infarction in elderly diabetic patients: association with serumsoluble adhesion molecules, D i a b e t o l o g i a 1998;41:911–917.
Elżbieta Pac-Kożuchowska. Evaluation of lipid parameters, homocysteine, adhesion molecules and carotid intima-media thickness in children from families with circulatory system diseases history,the journal of preventive medicine 2004;12 (3-4): 5-14
De Caterina R, Basta G, Lazzerini G, Dell’Omo G, Petrucci R, Morale M, et al.Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis, Arterioscler Thromb Vasc Biol 1997;17 : 26 46–2654.
Peter K, Nawroth P, Conradt C, Nordt T, Weiss T, Boehme M, et al.Circulating vascular cell adhesion molecule-correlates with the extent of human atherosclerosis in contrast to circulat- ing intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin, Arterioscler Thromb Vasc Biol 1997;17:505–512, 1997.
Farhan J Khawaja Iftikhar J Kullo. Novel markers of peripheral arterial disease, Vasc Med 2009;14(4): 381–392.
Shih-Jen Hwang, Christie M. Ballantyne, A. Richey Sharrett, Louis C. Smith, Clarence E. Davis, Antonio M. Gotto Jr, et al. Circulating Adhesion Molecules VCAM-1, ICAM-1, and E-selectin in Carotid Atherosclerosis and Incident Coronary Heart Disease Cases, Circulation 1997;96: 4219-4225.
Altannavch TS, Roubalova K, Kucera P, Andel M. Effect of High Glucose Concentrations on Expression of ELAM-1, VCAM-1 and ICAM-1 in HUVEC with and without Cytokine Activation, Physiol. Res 2004;53: 77-82, 2004
Raja B Singh, Sushma A Mengi, Yan-Jun Xu, Amarjit S Arneja, Naranjan S Dhalla. Pathogenesis of atherosclerosis: A multifactorial process, Exp Clin Cardiol 2002;7(1): 40–53.
Mach F. The role of chemokines in atherosclerosis, Curr Atheroscler Rep 2001;3:243–51.
Elena Galkina, Klaus Ley.Vascular Adhesion Molecules in Atherosclerosis. Arteriosclerosis, Thrombosis and Vascular Biology 2007;27: 2292-2301.
Matsumoto K, Sera Y, Nakamura H, Ueki Y, Miyake S. Serum concentrations of soluble adhesion molecules are related to degree of hyperglycemia and insulin resistance in patients with type 2 diabetes mellitus, Diabetes Res Clin Pract 2002;55: 131-138.
Rizzoni D, Porteri E, Guelfi D, et al. Endothelial dysfunction in small resistance arteries of patients with non-insulin-de- pendent diabetes mellitus. J Hypertens 2001; 19: 913–919.
Kowalska I, Strączkowska M, Szelachowska M. Circu- lating E-selectin, vascular cell adhesion molecule-1, and in- tercellular adhesion molecule-1 in men with coronary artery disease assessed by angiography and disturbances of car- bohydrate metabolism, Metabolism 2002;51: 733–736.
Matsumoto K, Sera Y, Ueki Y Inukai G, Niiro E, Miyake S. Comparison of serum concentrations of soluble adhesion molecules in diabetic microangiopathy and macroangiopa- thy, Diabet Med 2002;19: 822–826.
Weissberg P. Mechanisms modifying atherosclerotic disease from lipids to vascular biology, Atherosclerosis 1999;147: 3–10.
Ewa R, Jolanta J, Bronisława S, Celina W, Krzysztof S, Łukasz S, etal. Evaluation of VCAM-1 and PAI-1 concentration in diabetes mellitus patients, Diabetologia Doświadczalna i Kliniczna 2008;8:85-88.
Ohshita K, Yamane K, Hanafusa M, Mori H, Mito K, Okubo M, etal. Elevated white blood cell count in sub- jects with impaired glucose tolerance, Di- abetes Care 2004;27:491–496.
Wei Xu1, Hai-feng Wu, Shao-gang Ma, Feng Bai, Wen Hu, Yue Jin, etal. Correlation between Peripheral White Blood Cell Counts and Hyperglycemic Emergencies, Int J Med Sci 2013;10(6):758-765.
Elyse D M, Stephen P G, Karin J D. Diabetes Alters Activation and Repression of Pro- and Anti-Inflammatory Signaling Pathways in the Vasculature, Front Endocrinol (Lausanne)2013;4: 68.
Ann Marie Schmidt, Osamu Hori, Jing Xian Chen, Jian Feng Li, Jill Crandall, Jinghua Zhang, etal.Advanced Glycation Endproducts Interacting with Their Endothelial Receptor Induce Expression of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Cultured Human Endothelial Cells and in Mice, The Journal of Clinical Investigation 1995;96: 1395-1403.
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
Tel: (001)347-983-5186